Audience:
Neurologists and other healthcare professionals Lilly and FDA revised the WARNINGS
section of the prescribing information to inform healthcare professionals of reports
of cardiac valvulopathy involving one or more valves in patients receiving Permax
therapy.
*Many cases are in
the investigative stages, but make a complaint now and your case can be evaluated.
Find out if you are owed money for damages and injury?